Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 3751-3800 of 6028 result(s).
CYDY CytoDyn Inc
03/10/2021 1:30:37 AM
The problem is the absolute failure (3)
CYDY CytoDyn Inc
03/10/2021 1:19:00 AM
Both trials have ended so there wou
CYDY CytoDyn Inc
03/10/2021 12:20:31 AM
They could do an RO on those still (2)
CYDY CytoDyn Inc
03/09/2021 11:51:02 PM
IO Canada - We will never even file (14)
CYDY CytoDyn Inc
03/09/2021 11:06:42 PM
I believe cancer BTD is good result (3)
CYDY CytoDyn Inc
03/09/2021 10:41:36 PM
Proprietary information, most likel
CYDY CytoDyn Inc
03/09/2021 10:25:34 PM
The target treatment group for HIV (1)
CYDY CytoDyn Inc
03/09/2021 6:56:45 AM
It's amazing how non-shareholders c (4)
CYDY CytoDyn Inc
03/09/2021 2:04:02 AM
It is primitive compared to researc (5)
CYDY CytoDyn Inc
03/09/2021 1:38:16 AM
speaker bureaus aka graft
CYDY CytoDyn Inc
03/08/2021 9:52:52 PM
What is remdesivir's benefit in the (1)
CYDY CytoDyn Inc
03/08/2021 9:42:30 PM
At day 5, there was a reduction But
CYDY CytoDyn Inc
03/08/2021 8:31:49 PM
Why? (1)
CYDY CytoDyn Inc
03/08/2021 7:56:24 PM
No drug company is obliged to provi (1)
CYDY CytoDyn Inc
03/08/2021 8:48:07 AM
I've said before I don't mind a mod (3)
CYDY CytoDyn Inc
03/08/2021 8:42:24 AM
An ongoing CD10 phase 3 with a prop (6)
CYDY CytoDyn Inc
03/08/2021 8:11:45 AM
When they're randomized Amarex woul (7)
CYDY CytoDyn Inc
03/08/2021 8:05:55 AM
The BLA problem was a failure to ac (6)
CYDY CytoDyn Inc
03/07/2021 11:49:34 PM
It's obvious that the EUA's "may pr (8)
CYDY CytoDyn Inc
03/07/2021 11:47:54 PM
Most likely those that are mechanic (1)
CYDY CytoDyn Inc
03/07/2021 10:42:55 PM
The FDA should approve the protocol (4)
CYDY CytoDyn Inc
03/07/2021 10:27:15 PM
But do you really think the price w (5)
CYDY CytoDyn Inc
03/07/2021 10:15:57 PM
I thought I had only mentioned mort (3)
CYDY CytoDyn Inc
03/07/2021 9:23:41 PM
Ask Dr. Patterson about post study (1)
CYDY CytoDyn Inc
03/07/2021 9:06:17 PM
I think the 140 patient trial shoul (2)
CYDY CytoDyn Inc
03/07/2021 9:04:16 PM
The OLE patients couldn't be added
CYDY CytoDyn Inc
03/07/2021 8:58:43 PM
I hate to sound negative, but the w (4)
CYDY CytoDyn Inc
03/07/2021 8:35:07 PM
Great data from CD 10 but too many (4)
CYDY CytoDyn Inc
03/07/2021 8:26:10 PM
Critical over 65 not severe . And t (2)
CYDY CytoDyn Inc
03/07/2021 8:21:48 PM
I am not sure if the CYDY study con (4)
CYDY CytoDyn Inc
03/07/2021 8:15:26 PM
MAYBE more skilled management would (3)
CYDY CytoDyn Inc
03/07/2021 4:48:31 AM
All that being said, the results sh (4)
CYDY CytoDyn Inc
03/06/2021 9:24:57 PM
Nasdaq uplist needs cash on hand to (2)
CYDY CytoDyn Inc
03/06/2021 8:59:50 PM
I had said the the 5% not successfu (6)
CYDY CytoDyn Inc
03/06/2021 7:12:25 PM
dr. been 6pm pacific time https://w (2)
CYDY CytoDyn Inc
03/06/2021 12:00:16 AM
who had received mechanical ventila
CYDY CytoDyn Inc
03/05/2021 10:28:44 PM
Not quite comparable since death fr (1)
CYDY CytoDyn Inc
03/05/2021 9:22:10 PM
Piling an immunosuppressant on top (3)
CYDY CytoDyn Inc
03/05/2021 9:16:25 PM
I was referring to publication in a (3)
CYDY CytoDyn Inc
03/05/2021 9:02:54 PM
What I would like to know is what p (3)
CYDY CytoDyn Inc
03/05/2021 8:56:38 PM
Keep them closed until after the CC
CYDY CytoDyn Inc
03/05/2021 8:24:04 PM
There is no doubt they are referrin (6)
CYDY CytoDyn Inc
03/05/2021 7:48:37 PM
Waiting for a peer reviewed publica (1)
CYDY CytoDyn Inc
03/05/2021 7:40:52 PM
no (1)
CYDY CytoDyn Inc
03/05/2021 7:06:27 PM
8
CYDY CytoDyn Inc
03/05/2021 6:44:10 PM
Under "may show benefit" an EUA sho (4)
CYDY CytoDyn Inc
03/05/2021 6:30:51 PM
Only 62 critical patients threw thi
CYDY CytoDyn Inc
03/05/2021 6:15:17 PM
Heard from an acquaintance of an ac (1)
CYDY CytoDyn Inc
03/05/2021 6:10:28 PM
Some say Nader is holding strong, h (7)
CYDY CytoDyn Inc
03/05/2021 4:30:51 PM
With a partnership is the loss of c (6)
Go to page:
  • << First
  • < Previous
  • 75
  • 76
  • Next >

Recent Articles

  • Trump Engages TikTok Advocating Accountability for Media
  • Understanding Economic Inequality Through Robert Reich's Lens
  • Rent Surges in NYC’s Top Neighborhoods Amid Economic Shifts
  • Navigating Investor Rights: Semler Scientific Case Update
  • Trump Intensifies Rhetoric Against Soros Amid Controversy
  • Breast Cancer Antibody Drug Conjugates: Opportunities Ahead
  • Important Update for SelectQuote, Inc. Investors on Class Action
  • Cornelius D. Jones Joins Prestigious Academy of Authors
  • Lantheus Holdings Faces Class Action: Investors Urged to Act
  • Hyundai's Supernal Faces Leadership Changes, Future Uncertain
  • Larry Ellison: From College Dropout to Tech Titan
  • Gold Producers Tackle Emissions with Mixed Results in ESG Metrics
  • China's Potential Ban on Flush Door Handles in Cars
  • Market Insights: Top 10 Large Cap Stocks Facing Declines
  • Crypto Landscape Shifts: Ethereum ETFs Surge Amid Market Changes
  • Investigating PACS Group, Inc.: Shareholder Concerns Addressed
  • Pomerantz Law Firm Launches Investigation on Freeport-McMoRan
  • Quanex Building Products Faces Potential Investor Claims Today
  • Geely Automobile Holdings: Investor Concerns and Legal Steps
  • MarineMax, Inc. Investors: Key Insights and Updates for HZO
  • Matrix Service Company Faces Scrutiny Over Investor Claims
  • Pomerantz Law Firm Investigates Potential Securities Fraud by BellRing Brands
  • Bumble Inc. Faces Legal Scrutiny Over Potential Securities Violations
  • Pomerantz Law Firm Launches Investigation into Agilon Health
  • Pomerantz Law Firm Reviews Securities Claims Against Synopsys
  • Investor Investigation: Duolingo, Inc. Faces Claims and Trends
  • Insperity, Inc. Under Investigation for Possible Securities Fraud
  • Class Action Filed Against Dow Inc. by Pomerantz Law Firm
  • Concerns Rise as Pomerantz Law Firm Investigates Fluor Corp
  • Big Week for Large-Cap Stocks: Top Gainers You Can't Miss
  • Celebrating Everlight Solar: Madison's Top Choice in 2025
  • Invest in Capricor Therapeutics: Upcoming Class Action Deadline
  • California's AI Safety Bill Awaits Final Authoritative Approval
  • Elon Musk Presses Microsoft CEO on Activision Blizzard Remarks
  • Optimove Leads with Innovative Solutions for iGaming Growth
  • Exploring America’s Race to Artificial Superintelligence
  • How Buck Sexton Highlights Leadership in the AI Arms Race
  • Elevate Your Skills: Join PayrollOrg’s Leadership Conference
  • Celebrating Fashion: A Night of Style With Calvin Klein
  • Recent Crypto Trends: Silver Surges and Dogecoin's Rise
  • Political Charges and Market Movements: A Crypto Perspective
  • Fangzhou's Innovative AI Technology Revolutionizes Health Care
  • Investigation into Lantheus Holdings by Securities Law Firm
  • Monopar Therapeutics Reveals Promising ALXN1840 Findings
  • Weekly Highlights in Mobility: EV Sales Surge and Uber Lawsuit
  • HKUST Strengthens Global Innovation Ties with Sweden
  • Monopar Showcasing Promising Long-Term Data for ALXN1840
  • Market Insights: iPhone 17 Unveiling and AI Growth Trends
  • Explore Dubai Effortlessly: Thrivestate's Unique Program
  • Court Deadline Approaches for RxSight Investors Amid Revelations
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site